Research map: Toward the prevention of clinically manifest Parkinson’s disease

Back to the article

Papers in this map

  1. Parkinson disease · Werner H Poewe · 2017 · 5208 citations · Cited by this paper
  2. Disease modification in advanced Parkinson’s disease: a review and roadmap for paving the way for next-generation interventions · 2026 · Related
  3. Parkinson's disease · Bastiaan R. Bloem · 2021 · 3923 citations · Cited by this paper
  4. Exploring the relationship between interoception and mental body representation in Parkinson’s disease · 2026 · Related
  5. Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup · Clifford R. Jack · 2024 · 2682 citations · Cited by this paper
  6. Clinicoepidemiological characteristics of autoimmune encephalitis in the philippines: a multicenter case series study · 2026 · Related
  7. MDS research criteria for prodromal Parkinson's disease · Daniela Berg · 2015 · 1338 citations · Cited by this paper
  8. Visual function and autism spectrum disorder · 2026 · Related
  9. Biomarkers for neurodegenerative diseases · Oskar Hansson · 2021 · 1179 citations · Cited by this paper
  10. Pallidotomy for severe Parkinson’s disease dyskinesia and other motor features in a resource-limited setting: the Philippine experience and review of the literature · 2026 · Related
  11. The Parkinson Pandemic—A Call to Action · Earl Ray Dorsey · 2017 · 1128 citations · Cited by this paper
  12. Treatment stability comparison among different ADD-ON therapies in fluctuating Parkinson’s disease patients: the role of clinical and demographic factors · 2026 · Related
  13. The pathogenesis of Parkinson's disease · Huw R. Morris · 2024 · 1008 citations · Cited by this paper
  14. Psychiatric disorders in amyotrophic lateral sclerosis: a short note · 2026 · Related
  15. Structure-based classification of tauopathies · Yang Shi · 2021 · 956 citations · Cited by this paper
  16. Prevalence and state-dependent patterns of non-motor fluctuations in Parkinson’s disease · 2026 · Related
  17. The epidemiology of Parkinson's disease · Yoav Ben‐Shlomo · 2024 · 939 citations · Cited by this paper
  18. Beyond “Advanced”: proposing Fluctuation-Dominant Parkinson’s disease as a functional alternative to enable timely device-aided therapy · 2026 · Related
  19. Structures of α-synuclein filaments from multiple system atrophy · Manuel Schweighauser · 2020 · 861 citations · Cited by this paper
  20. Ferroptosis in depression: mechanisms, association, and therapeutic strategies · 2026 · Related
  21. Update of the MDS research criteria for prodromal Parkinson's disease · Sebastian Heinzel · 2019 · 792 citations · Cited by this paper
  22. Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study · Andrew D. Siderowf · 2023 · 746 citations · Cited by this paper
  23. Structure of the toxic core of α-synuclein from invisible crystals · José A. Rodríguez · 2015 · 649 citations · Cited by this paper
  24. A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research · Tanya Simuni · 2024 · 630 citations · Cited by this paper
  25. Novel tau filament fold in corticobasal degeneration · Wenjuan Zhang · 2020 · 605 citations · Cited by this paper
  26. Projections for prevalence of Parkinson’s disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021 · Dongning Su · 2025 · 593 citations · Cited by this paper
  27. A biological classification of Parkinson's disease: the SynNeurGe research diagnostic criteria · Günter U. Höglinger · 2024 · 549 citations · Cited by this paper
  28. Advances in markers of prodromal Parkinson disease · Ronald B. Postuma · 2016 · 419 citations · Cited by this paper
  29. A biological classification of Huntington's disease: the Integrated Staging System · Sarah J. Tabrizi · 2022 · 338 citations · Cited by this paper
  30. Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids · Sjors H. W. Scheres · 2023 · 297 citations · Cited by this paper
  31. Medical, surgical, and physical treatments for Parkinson's disease · Tom Foltynie · 2024 · 241 citations · Cited by this paper
  32. Parkinson disease therapy: current strategies and future research priorities · Fabrizio Stocchi · 2024 · 192 citations · Cited by this paper
  33. β-adrenoreceptors and the risk of Parkinson's disease · Franziska Hopfner · 2020 · 77 citations · Cited by this paper
  34. Computational whole-body-exposome models for global precision brain health · Agustín M. Ibáñez · 2025 · 21 citations · Cited by this paper
  35. A Biomarker‐Based Classification of Corticobasal Syndrome · Carla Palleis · 2025 · 9 citations · Cited by this paper
  36. Clinical utility of digital technologies in Parkinson’s disease · Björn H. Falkenburger · 2025 · 5 citations · Cited by this paper
  37. Addressing Gaps in Parkinson's Disease Etiology: The Need for a Polyexposure Score · Njideka Ulunma Okubadejo · 2026 · 4 citations · Cited by this paper

Source: OpenAlex (CC0)